Effects of increased shielding on gamma-radiation levels within spacecraft

Haskins, P.S.; McKisson, J.; Weisenberger, A.G.; Ely, D.W.; Ballard, T.A.; Dyer, C. S.; Truscott, P.R.; Piercey, R. B.; Ramayya, A. V.; Camp, D.C.

doi:10.1016/0273-1177(92)90144-m

Search citation statements

Order By: Relevance

Paper Sections

Select...

Particles Trapped By the Earth's Magnetic Field1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1995

2022

Publication Types

Select...

Book3

Article2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 12 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 (Mehta and Bhayani 2017). So, the radiation environment inside the spacecraft is very complex and the cumulative radiation dose is very high compared to terrestrial environment (Mehta and Bhayani 2017;Haskins et al 1992;Benton et al 1984;Novikov et al 2009;Reitz et al 2005;Thirsk et al 2009;Lai 2011;Olesen 1966;Messenger and Ash 1997).…”

Section: Particles Trapped By the Earth's Magnetic Fieldmentioning

confidence: 99%

Physicochemical Stability of Space Medicines

Mehta

Bhayani

2020

Handbook of Space Pharmaceuticals

View full text Add to dashboard Cite

Astronauts' health and wellness maintenance in a unique, isolated, and extreme environment of space is a primary goal for a successful space mission. Safe, efficacious, and stable medications are essential to achieve this goal. The unique space environmental factors including microgravity, vibration, vacuum, varying temperature/humidity, and excessive radiation can alter drug stability during spaceflights. Stability of medicines used for space exploration missions cannot

show abstract